☆Trails Edge Capital Partners, LP
Quality Q
0.089
AUM ($M)
630
Positions
35
Turnover
0.38
Top-10 wt
50%
Herfindahl
0.039
History (qtrs)
3
Excess Return
+18.5%
AI Eval Run AI Eval
Holdings · 39 positions · portfolio value $630M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆LBRX funds › | LB PHARMACEUTICALS INC | ADD | — | 7.8% | +0.2% | 49.4 | 1,523,022 | +203,660 | 2 | — |
| ☆NRIX funds › | NURIX THERAPEUTICS INC | TRIM | — | 6.1% | -0.3% | 38.2 | 1,573,220 | -170,000 | 2 | — |
| ☆IMCR funds › | IMMUNOCORE HLDGS PLC | ADD | — | 5.4% | +0.5% | 33.8 | 1,063,234 | +380,637 | 2 | — |
| ☆TRAX funds › | FIRST TRACKS BIOTHERAPEUTICS | NEW | — | 4.8% | +4.8% | 30.5 | 1,514,000 | +1,514,000 | 1 | +4180.6% |
| ☆FDMT funds › | 4D MOLECULAR THERAPEUTICS IN | ADD | — | 4.7% | +1.8% | 29.6 | 2,227,917 | +925,000 | 2 | +36.0% |
| ☆BMRN funds › | BIOMARIN PHARMACEUTICAL INC | NEW | — | 4.7% | +4.7% | 29.3 | 512,000 | +512,000 | 1 | +229.9% |
| ☆DSGN funds › | DESIGN THERAPEUTICS INC | ADD | — | 4.6% | +2.5% | 29.0 | 2,001,282 | +1,149,269 | 2 | +87.5% |
| ☆XENE funds › | XENON PHARMACEUTICALS INC | HOLD | — | 4.2% | -1.8% | 26.6 | 440,000 | +0 | 2 | — |
| ☆MIRM funds › | MIRUM PHARMACEUTICALS INC | TRIM | — | 4.2% | -3.1% | 26.1 | 223,312 | -110,000 | 2 | — |
| ☆INSM funds › | INSMED INC | NEW | — | 3.9% | +3.9% | 24.6 | 230,331 | +230,331 | 1 | +57.5% |
| ☆CYTK funds › | CYTOKINETICS INC | TRIM | — | 3.9% | -0.8% | 24.5 | 288,089 | -11,911 | 2 | -7.0% |
| ☆SNDX funds › | SYNDAX PHARMACEUTICALS INC | ADD | — | 3.9% | -0.0% | 24.3 | 1,110,000 | +408,179 | 2 | -36.5% |
| ☆NGNE funds › | NEUROGENE INC | TRIM | — | 3.6% | -0.1% | 22.5 | 714,885 | -67,902 | 2 | — |
| ☆KLRA funds › | KAILERA THERAPEUTICS INC | NEW | — | 3.4% | +3.4% | 21.7 | 984,786 | +984,786 | 1 | -54.3% |
| ☆RVMD funds › | REVOLUTION MEDICINES INC | TRIM | — | 3.4% | -2.2% | 21.7 | 115,750 | -129,250 | 2 | +293.7% |
| ☆IKT funds › | INHIBIKASE THERAPEUTICS INC | ADD | — | 2.9% | -0.3% | 18.4 | 9,051,318 | +993,973 | 2 | — |
| ☆INCY funds › | INCYTE CORP | NEW | — | 2.8% | +2.8% | 17.6 | 155,000 | +155,000 | 1 | +138.7% |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | NEW | Common Stock | 2.6% | +2.6% | 16.5 | 891,881 | +891,881 | 1 | +98.0% |
| ☆MLTX funds › | MOONLAKE IMMUNOTHERAPEUTICS | NEW | — | 2.3% | +2.3% | 14.6 | 750,000 | +750,000 | 1 | -23.5% |
| ☆FTH funds › | FAETH THERAPEUTICS INC | ADD | — | 2.0% | +1.1% | 12.9 | 515,335 | +390,335 | 2 | +1208.4% |
| ☆XFOR funds › | X4 PHARMACEUTICALS INC | HOLD | — | 1.9% | -0.6% | 12.0 | 2,571,478 | +0 | 2 | — |
| ☆IRD funds › | OPUS GENETICS INC | ADD | — | 1.8% | +1.3% | 11.3 | 2,743,658 | +2,243,658 | 2 | -45.8% |
| ☆SLGL funds › | SOL-GEL TECHNOLOGIES LTD | ADD | — | 1.6% | +0.0% | 10.3 | 139,445 | +53,949 | 2 | +1.1% |
| ☆AURA funds › | AURA BIOSCIENCES INC | NEW | Common Stock | 1.6% | +1.6% | 10.2 | 1,443,333 | +1,443,333 | 1 | -11.5% |
| ☆IPSC funds › | CENTURY THERAPEUTICS INC | ADD | — | 1.6% | +0.3% | 10.1 | 4,134,969 | +1,684,976 | 2 | -32.6% |
| ☆IVA funds › | INVENTIVA SA | HOLD | — | 1.6% | -1.9% | 10.0 | 2,657,997 | +0 | 2 | — |
| ☆CAMP funds › | CAMP4 THERAPEUTICS CORP | TRIM | — | 1.3% | -0.7% | 8.4 | 1,932,937 | -6,626 | 2 | — |
| ☆ALT funds › | ALTIMMUNE INC | NEW | Common Stock | 1.3% | +1.3% | 8.1 | 2,660,000 | +2,660,000 | 1 | -1.8% |
| ☆NERV funds › | MINERVA NEUROSCIENCES INC | HOLD | — | 1.3% | -0.8% | 7.9 | 1,419,000 | +0 | 2 | -82.0% |
| ☆PMN funds › | PROMIS NEUROSCIENCES INC | HOLD | — | 1.2% | -0.5% | 7.3 | 557,103 | +0 | 2 | -47.5% |
| ☆OKUR funds › | ONKURE THERAPEUTICS INC | NEW | — | 1.0% | +1.0% | 6.6 | 1,438,456 | +1,438,456 | 1 | +168.6% |
| ☆FBRX funds › | FORTE BIOSCIENCES INC | NEW | — | 0.9% | +0.9% | 5.8 | 273,181 | +273,181 | 1 | — |
| ☆RACC funds › | RESEARCH ALLIANCE CORP III | NEW | — | 0.8% | +0.8% | 5.3 | 500,000 | +500,000 | 1 | +5866.4% |
| ☆VTVT funds › | VTV THERAPEUTICS INC | TRIM | — | 0.5% | -0.8% | 3.2 | 85,192 | -54,386 | 2 | — |
| ☆IMA funds › | IMAGENEBIO INC | NEW | — | 0.3% | +0.3% | 1.7 | 282,004 | +282,004 | 1 | -9.5% |
| ☆IMVT funds › | IMMUNOVANT INC | EXIT | — | 0.0% | -2.4% | 0.0 | 0 | -414,054 | 0 | — |
| ☆RCUS funds › | ARCUS BIOSCIENCES INC | EXIT | Common Stock | 0.0% | -5.3% | 0.0 | 0 | -1,047,935 | 0 | — |
| ☆DFTX funds › | DEFINIUM THERAPEUTICS INC | EXIT | — | 0.0% | -7.7% | 0.0 | 0 | -1,738,110 | 0 | +79.0% |
| ☆PCVX funds › | VAXCYTE INC | EXIT | — | 0.0% | -9.1% | 0.0 | 0 | -662,470 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 630 | 35 | 0.38 | 50% | 0.039 | 0.089 | — | in |
| 2026Q1 | 425 | 26 | 0.44 | 65% | 0.053 | 0.092 | — | entered |
| 2025Q4 | 405 | 23 | 0.00 | 69% | 0.059 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status